You are here

  • Home
  • Archive
  • Volume 74, Issue 6
  • The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study

Article info

Article menu
Clinical and epidemiological research
Extended report
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
Free

Authors

  • Elisabeth Lie Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Lars Erik Kristensen Section of Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden Musculoskeletal Statistics Unit, Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Helena Forsblad-d'Elia Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Tatiana Zverkova-Sandström Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Johan Askling Clinical Epidemiology Unit & Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Lennart T Jacobsson Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • for the ARTIS Study Group
    Google scholar articles
  1. Correspondence to Dr Elisabeth Lie, Department of Rheumatology, Diakonhjemmet Hospital, P.O. Box 23 Vinderen, Oslo N-0319, Norway; elisabeth_lie{at}yahoo.no
View Full Text

Citation

Lie E, Kristensen LE, Forsblad-d'Elia H, et al
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
Annals of the Rheumatic Diseases 2015;74:970-978.

Publication history

  • Received September 13, 2014
  • Revised February 1, 2015
  • Accepted February 2, 2015
  • First published February 20, 2015.
Online issue publication 
November 02, 2019

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions